Payment overview · 2025
General Payments
$19.55
1 reported records · 1 companies
Healthcare provider profile · identity verified
John D Johnston, MD
Allopathic & Osteopathic Physicians|Internal Medicine · BURLINGTON, NC · NPI 1649241894
Verified facts
What the public records show
CMS Open Payments records show John D Johnston, MD received $19.55 in general payments during 2025 across 1 reported records.
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $19.55 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $19.55 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19.55 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 786 | 208 |
| Amlodipine Besylate | Amlodipine Besylate | 755 | 204 |
| Levothyroxine Sodium | Levothyroxine Sodium | 633 | 143 |
| Omeprazole | Omeprazole | 548 | 140 |
| Losartan Potassium | Losartan Potassium | 538 | 147 |
| Metformin Hcl | Metformin Hcl | 504 | 126 |
| Hydrochlorothiazide | Hydrochlorothiazide | 496 | 131 |
| Lisinopril | Lisinopril | 452 | 127 |
| Gabapentin | Gabapentin | 428 | 103 |
| Alprazolam | Alprazolam | 386 | 62 |
| Simvastatin | Simvastatin | 386 | 101 |
| Pantoprazole Sodium | Pantoprazole Sodium | 359 | 97 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 329 | 90 |
| Tamsulosin Hcl | Tamsulosin Hcl | 299 | 77 |
| Furosemide | Furosemide | 272 | 78 |
| Potassium Chloride | Potassium Chloride | 265 | 71 |
| Sertraline Hcl | Sertraline Hcl | 258 | 54 |
| Metoprolol Succinate | Metoprolol Succinate | 241 | 67 |
| Citalopram Hbr | Citalopram Hydrobromide | 234 | 54 |
| Trazodone Hcl | Trazodone Hcl | 225 | 46 |
| Meloxicam | Meloxicam | 214 | 48 |
| Eliquis | Apixaban | 212 | 43 |
| Pravastatin Sodium | Pravastatin Sodium | 206 | 56 |
| Tramadol Hcl | Tramadol Hcl | 194 | 63 |
| Glipizide | Glipizide | 192 | 49 |
| Allopurinol | Allopurinol | 188 | 55 |
| Fluticasone Propionate | Fluticasone Propionate | 169 | 45 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 167 | 56 |
| Metoprolol Tartrate | Metoprolol Tartrate | 157 | 49 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 151 | 24 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 149 | 38 |
| Zolpidem Tartrate | Zolpidem Tartrate | 142 | 20 |
| Prednisone | Prednisone | 140 | 99 |
| Atenolol | Atenolol | 138 | 32 |
| Clopidogrel | Clopidogrel Bisulfate | 138 | 34 |
| Pioglitazone Hcl | Pioglitazone Hcl | 136 | 33 |
| Carvedilol | Carvedilol | 125 | 39 |
| Finasteride | Finasteride | 123 | 31 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 119 | 35 |
| Glimepiride | Glimepiride | 115 | 32 |
| Buspirone Hcl | Buspirone Hcl | 112 | 28 |
| Glipizide Er | Glipizide | 103 | 26 |
| Lovastatin | Lovastatin | 100 | 25 |
| Clonazepam | Clonazepam | 99 | 16 |
| Hydralazine Hcl | Hydralazine Hcl | 93 | 22 |
| Montelukast Sodium | Montelukast Sodium | 89 | 20 |
| Lorazepam | Lorazepam | 88 | 18 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 87 | 18 |
| Ropinirole Hcl | Ropinirole Hcl | 87 | 14 |
| Januvia | Sitagliptin Phosphate | 86 | 14 |
| Duloxetine Hcl | Duloxetine Hcl | 84 | 23 |
| Alendronate Sodium | Alendronate Sodium | 82 | 23 |
| Cephalexin | Cephalexin | 81 | 47 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 79 | 34 |
| Mirtazapine | Mirtazapine | 78 | 25 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 76 | 19 |
| Propranolol Hcl | Propranolol Hcl | 74 | 17 |
| Escitalopram Oxalate | Escitalopram Oxalate | 69 | 21 |
| Ozempic | Semaglutide | 65 | 14 |
| Quetiapine Fumarate | Quetiapine Fumarate | 65 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 63 | 12 |
| Metformin Hcl Er | Metformin Hcl | 63 | 14 |
| Enalapril Maleate | Enalapril Maleate | 58 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 58 | suppressed |
| Methocarbamol | Methocarbamol | 58 | 22 |
| Ezetimibe | Ezetimibe | 56 | 18 |
| Tizanidine Hcl | Tizanidine Hcl | 56 | 16 |
| Donepezil Hcl | Donepezil Hcl | 55 | 16 |
| Oxycodone Hcl | Oxycodone Hcl | 55 | 12 |
| Benazepril Hcl | Benazepril Hcl | 51 | 15 |
| Doxycycline Hyclate | Doxycycline Hyclate | 51 | 45 |
| Spironolactone | Spironolactone | 51 | 20 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 51 | 14 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 51 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 49 | 12 |
| Warfarin Sodium | Warfarin Sodium | 48 | 13 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 46 | 41 |
| Chlorthalidone | Chlorthalidone | 46 | 13 |
| Gemfibrozil | Gemfibrozil | 46 | suppressed |
| Pregabalin | Pregabalin | 46 | suppressed |
| Celecoxib | Celecoxib | 45 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 44 | 11 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 44 | 12 |
| Jardiance | Empagliflozin | 43 | 12 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 42 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 42 | suppressed |
| Klor-Con M20 | Potassium Chloride | 40 | 18 |
| Famotidine | Famotidine | 39 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 39 | suppressed |
| Ondansetron Odt | Ondansetron | 39 | 19 |
| Amitriptyline Hcl | Amitriptyline Hcl | 38 | 12 |
| Breo Ellipta | Fluticasone/Vilanterol | 38 | suppressed |
| Xarelto | Rivaroxaban | 38 | suppressed |
| Irbesartan | Irbesartan | 37 | suppressed |
| Nystatin | Nystatin | 37 | 22 |
| Aripiprazole | Aripiprazole | 36 | suppressed |
| Diazepam | Diazepam | 36 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 36 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 35 | 15 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 34 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 34 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 33 | 12 |
| Fluconazole | Fluconazole | 32 | 15 |
| Paroxetine Hcl | Paroxetine Hcl | 31 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 31 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 30 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 30 | suppressed |
| Azithromycin | Azithromycin | 29 | 23 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 29 | suppressed |
| Naproxen | Naproxen | 29 | 11 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 29 | suppressed |
| Memantine Hcl | Memantine Hcl | 28 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 28 | suppressed |
| Synthroid | Levothyroxine Sodium | 27 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 27 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 26 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 25 | 21 |
| Linzess | Linaclotide | 25 | suppressed |
| Carbamazepine | Carbamazepine | 24 | suppressed |
| Hydrocortisone | Hydrocortisone | 24 | suppressed |
| Levofloxacin | Levofloxacin | 23 | 23 |
| Ramipril | Ramipril | 23 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 22 | 11 |
| Temazepam | Temazepam | 22 | suppressed |
| Verapamil Er | Verapamil Hcl | 22 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 21 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 21 | suppressed |
| Telmisartan | Telmisartan | 21 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 20 | suppressed |
| Baclofen | Baclofen | 20 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Testosterone | Testosterone | 20 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 19 | 16 |
| Acyclovir | Acyclovir | 18 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 18 | suppressed |
| Calcitriol | Calcitriol | 17 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 17 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 17 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 17 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 17 | suppressed |
| Torsemide | Torsemide | 17 | 11 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 16 | suppressed |
| Nifedipine Er | Nifedipine | 16 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 16 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 15 | suppressed |
| Bupropion Xl | Bupropion Hcl | 15 | suppressed |
| Creon | Lipase/Protease/Amylase | 15 | suppressed |
| Estradiol (Once Weekly) | Estradiol | 15 | suppressed |
| Invokana | Canagliflozin | 15 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 15 | 15 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 15 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 14 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 14 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 14 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 14 | suppressed |
| Estradiol | Estradiol | 14 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 14 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 14 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 14 | suppressed |
| Tretinoin | Tretinoin | 14 | suppressed |
| Belsomra | Suvorexant | 13 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 13 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 13 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 13 | 13 |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 12 | suppressed |
| Dutasteride | Dutasteride | 12 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 12 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 12 | suppressed |
| Premarin | Estrogens, Conjugated | 12 | suppressed |
| Sucralfate | Sucralfate | 12 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 12 | suppressed |
| Trulicity | Dulaglutide | 12 | suppressed |
| Levetiracetam Er | Levetiracetam | 11 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 11 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 11 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $19.55 · 1 records | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error